In AD, activated DAPK1/NDRG2 pathways lead to cell death, and DAPK1 triggers the amyloidogenic pathway and Aβ production by phosphorylating APP (Kim et al., 2016; Xu et al., 2019). This evidence concerns the gene DAPK1 and Alzheimer disease.